Programmatic Advertising for Pharma Marketers

Pharmaceutical marketers can leverage programmatic advertising and comply with HIPAA, GDPR, ITP 2.2, CCPA and other privacy regulations.

Traditionally big advertising spenders, pharmaceutical marketers accounted for just 2.8% of programmatic advertising spend in 2019.

And yet, programmatic is rife with opportunity for the pharma industry – as long as marketers understand how to leverage its benefits while remaining privacy compliant.

In Programmatic Advertising for Pharma Marketers, you’ll learn:

Privacy regulations in pharmaceutical marketing

Privacy is of particular concern for pharmaceutical marketers. This report breaks down how to comply with privacy regulations including HIPAA, ITP 2.2, GDPR and CCPA.

Top challenges for pharma marketing

Learn how to address brand safety as well as safeguard both your brand and consumers’ privacy. Understanding scale and attribution also are crucial to pharma marketing success.

Programmatic Advertising for Pharma Marketers takes a look at these concerns as well as other top pharma marketing challenges.

Pharma marketing strategy for emerging platforms

Historically, linear TV and print have ruled the day for pharma marketers, but they can find success with emerging channels like connected TV, digital out-of-home and programmatic audio. Pharma marketers can embrace emerging technology while remaining privacy compliant.

Download the report to learn more.

For questions on the report’s research findings, or for press inquiries, please contact Viant’s Growth Marketing department at

Download the Report

Note: By filling out this form, you agree to the Viant Privacy Policy and to join Viant’s mailing list from which you can unsubscribe at any time.

Start driving down your DSP cost today! Get Started